Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141827 |
| CAS No | NA |
| Mol.F. | C6H11N3O3 |
| Mol.Wt. | 173.17 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141828 |
| CAS No | NA |
| Mol.F. | C17H22N6O5 |
| Mol.Wt. | 390.40 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141829 |
| CAS No | NA |
| Mol.F. | C26H32ClN7O5 |
| Mol.Wt. | 558.04 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141830 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O3 |
| Mol.Wt. | 457.92 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141831 |
| CAS No | NA |
| Mol.F. | C16H20N4O3S |
| Mol.Wt. | 348.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141832 |
| CAS No | NA |
| Mol.F. | C29H35N7O4S |
| Mol.Wt. | 577.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141833 |
| CAS No | NA |
| Mol.F. | C19H29N5O5S2 |
| Mol.Wt. | 471.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141834 |
| CAS No | NA |
| Mol.F. | C17H19N4O3S |
| Mol.Wt. | 359.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141835 |
| CAS No | NA |
| Mol.F. | C20H26N5O5S2 |
| Mol.Wt. | 480.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141836 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141837 |
| CAS No | NA |
| Mol.F. | C7H8N4O2 |
| Mol.Wt. | 180.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141838 |
| CAS No | NA |
| Mol.F. | C12H13N3O6 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141839 |
| CAS No | NA |
| Mol.F. | C17H15N3O4 |
| Mol.Wt. | 325.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141840 |
| CAS No | NA |
| Mol.F. | C18H22N6O4 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141841 |
| CAS No | NA |
| Mol.F. | C17H20N6O6 |
| Mol.Wt. | 404.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141842 |
| CAS No | 145438-97-7 |
| Mol.F. | C7H10N6O3 |
| Mol.Wt. | 226.2 |
| INV STATUS | CUSTOM SYNTHESIS |